Scarica l'app Stockscreener
779.67
0.35%
-2.71
Dopo l'orario di chiusura:
780.00
0.33
+0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché REGN Giù?
Forum
Previsione
Precedente Chiudi:
$782.38
Aprire:
$775
Volume 24 ore:
612.68K
Relative Volume:
0.67
Capitalizzazione di mercato:
$82.43B
Reddito:
$14.34B
Utile/perdita netta:
$4.50B
Rapporto P/E:
18.76
EPS:
41.5626
Flusso di cassa netto:
$3.77B
1 W Prestazione:
-2.93%
1M Prestazione:
+6.25%
6M Prestazione:
+31.92%
1 anno Prestazione:
+12.02%
Intervallo 1D:
$770.00
$781.46
Intervallo di 1 settimana:
$770.00
$815.00
Portata 52W:
$476.49
$821.11
Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile
Nome
Regeneron Pharmaceuticals Inc
Settore
Industria
Telefono
(914) 847-7000
Indirizzo
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Compare REGN vs VRTX, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
REGN
Regeneron Pharmaceuticals Inc
|
779.67 | 82.71B | 14.34B | 4.50B | 3.77B | 41.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.90 | 119.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
ARGX
Argen X Se Adr
|
844.41 | 52.43B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
336.19 | 45.01B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
362.14 | 39.23B | 4.98B | 69.60M | 525.67M | 0.5198 |
Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2025-12-03 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-24 | Iniziato | HSBC Securities | Buy |
| 2025-11-24 | Ripresa | Truist | Buy |
| 2025-11-13 | Iniziato | Scotiabank | Sector Perform |
| 2025-08-14 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-06-30 | Downgrade | Argus | Buy → Hold |
| 2025-05-30 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-30 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-02-05 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-09-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-12 | Iniziato | Bernstein | Outperform |
| 2024-01-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-08-21 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-08-21 | Reiterato | Oppenheimer | Perform |
| 2023-06-28 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-03-27 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2023-03-24 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-03-23 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2023-01-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2023-01-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-26 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2022-10-17 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-09-09 | Aggiornamento | Jefferies | Underperform → Hold |
| 2022-09-09 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-07-25 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-07-13 | Iniziato | Cantor Fitzgerald | Neutral |
| 2022-06-06 | Iniziato | Jefferies | Underperform |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2022-01-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-01-03 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2021-12-15 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2021-12-09 | Ripresa | Wells Fargo | Overweight |
| 2021-12-07 | Ripresa | Cowen | Market Perform |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Ripresa | BMO Capital Markets | Outperform |
| 2021-11-05 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-06-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-01-25 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2021-01-13 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2021-01-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-10-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-08-20 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-07-09 | Aggiornamento | SunTrust | Hold → Buy |
| 2020-05-26 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-17 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-04-08 | Iniziato | The Benchmark Company | Hold |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-02-26 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2020-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-02-11 | Aggiornamento | Argus | Hold → Buy |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-16 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-12-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-11-12 | Iniziato | SunTrust | Hold |
| 2019-11-07 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-09-23 | Aggiornamento | Guggenheim | Neutral → Buy |
Mostra tutto
Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie
Regeneron: A Long-Term Investment in Biotech - Intellectia AI
BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $900 From $850, Maintains Outperform Rating - marketscreener.com
Regeneron Pharmaceuticals, Inc. $REGN is Persistent Asset Partners Ltd's 5th Largest Position - MarketBeat
Is Wall Street Bullish or Bearish on Regeneron Pharmaceuticals Stock? - Barchart.com
China Universal Asset Management Co. Ltd. Has $12.01 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Compass Wealth Management LLC Invests $2.04 Million in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Diabetic Macular Edema Market to Reach US$ 7.44 Billion by 2033 - openPR.com
Regeneron (REGN) Awaits FDA Decision on FOP Treatment - GuruFocus
CEO Change: Can Regeneron Pharmaceuticals Inc grow without external funding2025 Big Picture & Weekly Momentum Stock Picks - baoquankhu1.vn
Here's What Analysts Are Saying About Regeneron Pharmaceuticals (REGN) - Finviz
Here’s What Analysts Are Saying About Regeneron Pharmaceuticals (REGN) - Insider Monkey
Regeneron Pharmaceuticals Says its FOP Drug Candidate Garetosmab's BLA Gets US FDA Priority Review - marketscreener.com
Regeneron Pharmaceuticals Inc. Lowers Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Regeneron (REGN) Gains Priority Review for Garetosmab - GuruFocus
Regeneron Gets Speedy FDA Review of Garetosmab in FOP - marketscreener.com
FDA grants priority review for Regeneron’s FOP treatment - Investing.com
Regeneron wins FDA review for rare disease therapy (REGN) - Seeking Alpha
Garetosmab biologics license application accepted for FDA priority review - marketscreener.com
FDA eyes first FOP treatment as garetosmab gets Priority Review - Stock Titan
PNC Financial Services Group Inc. Has $9.74 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
HighTower Advisors LLC Buys 1,944 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Where is Regeneron Pharmaceuticals (REGN) headed according to analysts? - MSN
Ex-Dividend Reminder: ONE Gas, AstraZeneca and Regeneron Pharmaceuticals - Nasdaq
Merit Financial Group LLC Buys 1,397 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Skandinaviska Enskilda Banken AB publ Lowers Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Fifth Third Bancorp Raises Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Vanguard Group Inc. Trims Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Shell Asset Management Co. Has $276,000 Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Pallas Capital Advisors LLC Takes $1.32 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Ocular Therapeutix Eyes FDA Filing After Wet AMD Drug Tops Regeneron’s Eylea in Phase 3 Test - MedCity News
Eylea threatened Inlyta Ocular’s phase III win with Axpaxli? - BioWorld MedTech
NEOS Investment Management LLC Increases Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
GSA Capital Partners LLP Purchases 1,358 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Regeneron (REGN) Downgraded at RBC Capital, Price Target Cut Sharply - MSN
Price Over Earnings Overview: Regeneron PharmaceuticalsRegeneron Pharmaceuticals (NASDAQ:REGN) - Benzinga
Assetmark Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Why is Regeneron Pharmaceuticals Inc. stock going downTrade Exit Report & AI Optimized Trade Strategies - mfd.ru
Aberdeen Group plc Sells 52,247 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Downgraded by Wall Street Zen to Hold - MarketBeat
Market Review: What are the future prospects of Regeneron Pharmaceuticals IncMarket Volume Report & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Caprock Group LLC Takes $1.47 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Is Regeneron Pharmaceuticals Inc. attractive at current valuationJuly 2025 Intraday Action & Expert Curated Trade Setup Alerts - mfd.ru
Is Regeneron Pharmaceuticals Inc. (RGO) stock in buy zone after pullback2025 Analyst Calls & High Accuracy Investment Signals - mfd.ru
Varma Mutual Pension Insurance Co Increases Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by Wealthfront Advisers LLC - MarketBeat
LSV Asset Management Takes $31.26 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Cibc World Market Inc. Has $8.85 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Allergy Data And Dupixent Insights Shape Immunology Growth Story - simplywall.st
CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens - Benzinga
Regeneron Allergy Antibodies And Dupixent Data Reframe Growth Prospects - Yahoo Finance
Regeneron Pharmaceuticals Inc Azioni (REGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):